• US Stocks
  • Amgen Inc.
Amgen Inc.

Amgen Inc.

HealthcareLarge Cap 
  • $ 236.76

    Stock Price

  • -$ 1.27(-0.53%)

    Last Change

About the company

Amgen Inc.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of illness in the areas of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The company's products include Evenity to treat osteoporosis in postmenopausal women; Prolia to treat postmenopausal women with osteoporosis; Xgeva for the prevention of skeletal-related events; Repatha to treat coronary artery diseases; Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Parsabiv to treat secondary hyperparathyroidism (sHPT); and Erenumab for the prevention of chronic migraine. Its products also comprise Blincyto to treat patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia; Kyprolis, a proteasome inhibitor to treat patients with multiple myeloma and small-cell lung cancer; Nplate, a thrombopoietic compound; AMJEVITA to treat psoriatic arthritis and polyarticular juvenile idiopathic arthritis, as well as ankylosing spondylitis and moderate-to-severe rheumatoid arthritis; ABP 215 for biosimilar candidates; and ABP 980 to treat human epidermal growth factor receptor 2-positive early breast cancer. The company's other marketed products include Neulasta, a pegylated protein to treat cancer patients; Aranesp to treat anemia; Sensipar/Mimpara products for use to treat sHPT in chronic kidney disease; EPOGEN to treat a lower-than-normal number of red blood cells; NEUPOGEN, a recombinant-methionyl human granulocyte colony-stimulating factor; and IMLYGIC to treat various cancer cells. It serves pharmaceutical wholesale distributors; and physicians or their clinics, dialysis centers, hospitals, and pharmacies, as well as consumers. The company has collaborative agreements with Pfizer Inc.; UCB; and Bayer HealthCare Pharmaceuticals Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
View More
    Total Revenue
    $ 6.594 B
    Cost of Revenue
    $ 1.510 B
    Gross Profit
    $ 5.084 B
    Operating Income
    $ 2.718 B
Scripbox Recommended US Equity Funds
Want to get exposure to US Equity with the ease of Mutual Funds?Learn more

Price chart

$ 239.55

1D High

$ 0.00

1D Low

-$ 1.27 (-0.53%)

1D Change

Last updated on 

Previous Close
$ 238.03
Open Price
$ 239.61
52 Week High
$ 292.06
52 Week Low
$ 219.83
PE Ratio
Avg. Volume
Market Cap
$ 126.424 B


Stock NameStock Price52 Week High52 Week LowCapital
Abbott Laboratories
Abbott Laboratories
$ 98.46$ 122.66$ 92.83Large Cap
$ 143.12$ 162.75$ 128.24Large Cap
$ 155.56$ 181.77$ 151.23Large Cap
$ 56.28$ 78.63$ 55.70Large Cap
$ 39.27$ 43.84$ 32.35Large Cap
$ 66.16$ 86.09$ 65.90Large Cap
$ 261.22$ 311.88$ 187.16Large Cap
$ 128.38$ 248.87$ 127.37Large Cap
$ 32.34$ 53.25$ 31.77Large Cap
$ 745.95$ 800.78$ 366.69Large Cap

Frequently Asked Questions

What is the price of Amgen Inc. share today in India?

Today, on 19th Apr 2024, the price of Amgen Inc. Shares in India is $ 236.76.

What was the highest Amgen Inc. share stock price?

The highest Amgen Inc. stock price was $ 292.06 till 19th Apr 2024 within the past 52 weeks.

What is the lowest price of AMGN shares?

The lowest AMGN stock price was $ 219.83 on 19th Apr 2024 within the past 52 weeks.

How to buy AMGN shares in India?

You can buy AMGN shares in India through Scripbox in just 4 simple steps. The process is simple, seamless, and paperless.
  • Create an account and submit KYC documents
  • On successful KYC, transfer amount required for investment
  • Invest in US stocks
  • Track and manage investments through Scripbox dashboard

Is Amgen Inc. shares Listed on NSE or BSE?

No, AMGN shares are not listed on NSE or BSE. Amgen Inc. is listed on the NASDAQ stock exchange.

Can I buy Amgen Inc. shares in India?

Yes, you can buy Amgen Inc. shares in India by simply opening an account with Scripbox.

Can I buy fractional shares of Amgen Inc.?

Yes, you can buy fractional shares of Amgen Inc. with Scripbox.

What is the P/E ratio for Amgen Inc. shares?

As on 19th Apr 2024, the P/E ratio for Amgen Inc. shares is 19.55.

What is the traded volume of Amgen Inc. shares?

As on 19th Apr 2024, the traded volume for Amgen Inc. shares is 2.129 M.

What is the market capitalization of Amgen Inc. shares?

Amgen Inc. shares has a market capitalization of $ 126.424 B.